Blocking dht should bring it back. So why does fin mostly just hold the line? 6/6/2026
Finasteride mainly prevents further hair loss by blocking DHT but doesn't reverse existing damage, while minoxidil can promote regrowth by waking dormant follicles. Ketoconazole helps with inflammation, but none of these treatments can reverse fibrosis or structural changes around hair follicles.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity Day 55 of minoxidil and finasteride
A 20-year-old is using oral and topical finasteride, topical minoxidil, ketoconazole shampoo, rosewater, Adgain tablets, creatine, and derma stamping to address hair loss. There is a debate about creatine's impact on hair loss, with some suggesting it increases DHT, while others disagree.
community Finasteride + Minoxidil 6-Week Update
A 40-year-old man experiencing male pattern baldness reports noticeable hair regrowth after 6 weeks of using finasteride 1 mg daily, topical minoxidil 5% twice a day, and ketoconazole shampoo twice a week. He has not experienced any side effects and plans to continue monitoring his progress.
community Does ketokonazole on its own improve androgenetic alopecia?
Ketoconazole can slightly improve hair density and is best used as an adjunct to treatments like finasteride and minoxidil. It helps with scalp health but won't stop androgenetic alopecia on its own.
community Been on min+fin for 2 years, only gotten worse. B/A pics included
The user experienced worsening hair loss despite using finasteride and topical minoxidil for two years and is considering oral minoxidil and dutasteride. Suggestions include microneedling, stress management, and alternative treatments like topical finasteride or ketoconazole shampoo.
community DUPA/Retrograde might not be DHT based...GET A BIOPSY QUICK or permanent Hair Loss!
DUPA and retrograde alopecia may not be solely DHT-based, and a biopsy is crucial for accurate diagnosis and treatment. Treatments mentioned include dutasteride, oral minoxidil, pioglitazone, clobetasol, calcipotriol, ketoconazole, and doxycycline, depending on the specific condition.
Related Research
6 / 6 results
research Hair Restoration in Androgenetic Alopecia: Looking Beyond Minoxidil, Finasteride and Hair Transplantation
This review discusses the emerging pathophysiological factors and potential new therapies for androgenetic alopecia beyond traditional treatments, but reports no new results.
research Entendendo a alopecia androgenética Understanding androgenetic alopecia Educação Médica Continuada
This study discusses the physiopathogeny, clinical manifestations, and treatment objectives of androgenetic alopecia without reporting new clinical findings.
research Controversy: is there a role for adjuvants in the management of male pattern hair loss?
This article reviews current hair loss treatments, proposing a hypothesis that a combination of drugs, supplements, and therapies may effectively manage hair loss, but presents no new clinical results.
research Androgenetic alopecia: An update
This study describes androgenetic alopecia as a common non-scarring hair loss condition primarily influenced by genetic factors and androgen sensitivity, notably impacting psychosocial well-being, especially in females and younger males seeking treatment.
research Pathophysiology of Androgenetic Alopecia and Implications for Treatment: An Overview of Current Literature
Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.
research Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment
This review article examines current drugs for androgenetic alopecia, focusing on their mechanisms and clinical efficacy, noting that while finasteride and minoxidil are commonly approved treatments, new drugs targeting different pathogenic pathways have emerged, offering a broader understanding and reference for AGA treatment options.